Distinguished surgeon, professor, researcher leads cancer center
An IU Health Goshen Release
January 10, 2013
GOSHEN, Ind. – Dr. Roderich Schwarz, most recently chair of surgical oncology at University of Texas Southwestern Medical Center in Dallas, now leads IU Health Goshen Center for Cancer Care as its medical director. Dr. Schwarz took the helm on Monday, Jan. 7. UT Southwestern Medical Center is among the top 25 medical schools and biomedical research institutions in the country.
As medical director, Dr. Schwarz—a practicing surgical oncologist who earned both an M.D. degree and a Ph.D. in experimental pathology—leads all clinical program activities, including research and physician recruitment, and will set the strategic clinical vision for the Center for Cancer Care.
Later this year Dr. Schwarz will join the IU School of Medicine as a professor of surgery and will continue his research activities at the Harper Cancer Research Institute, a partnership between the University of Notre Dame and IU School of Medicine South Bend. He was a professor of surgery and the Mark and Jane Gibson Distinguished Professor of Cancer Research at UT Southwestern Medical School.
“Because we continue to expand our cancer research and treatment capabilities at IU Health Goshen, we needed to find a cutting-edge leader in the field with expertise both as a practitioner and a researcher,” says IU Health Goshen President and CEO Randy Christophel. “But just as important as his skill is his approach to cancer care. He is known for his collaboration with other leaders in the field, and takes a patient-centered approach to his care. He is a great fit.”
Dr. Schwarz focuses his laboratory research and clinical trials on gastrointestinal cancers, particularly pancreatic cancer. He is a well-published author, with scholarly articles appearing in the Journal of Clinical Oncology, the Annals of Surgical Oncology, and the Journal of the American College of Surgeons, among many others.
A native of Germany, Dr. Schwarz received his M.D. and experimental pathology doctorate degree from the Medical School of Hannover in Germany. He completed his general surgery residency in the United States at the University of Pittsburgh School of Medicine after a three-year postdoctoral research fellowship at the Pittsburgh Cancer Institute, and completed his training with a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York City.